{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18084912", "DateCompleted": {"Year": "2008", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0071-786X", "JournalIssue": {"Volume": "65", "PubDate": {"Year": "2008"}}, "Title": "Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques", "ISOAbbreviation": "Prog Drug Res"}, "ArticleTitle": "Mother Nature's gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery.", "Pagination": {"StartPage": "1", "EndPage": "44", "MedlinePgn": "1, 3-44"}, "Abstract": {"AbstractText": ["This chapter is designed to demonstrate that compounds derived from nature are still in the forefront of drug discovery in diseases such as microbial and parasitic infections, carcinomas of many types and control of cholesterol/lipids in man. In each disease area we have provided short discussions of past, present and future agents, in general only considering compounds currently in clinical Phase II or later, that were/are derived from nature's chemical skeletons. Finishing with a discussion of the current and evolving role(s) of microbes (bacteria and fungi) in the production of old and new agents ostensibly produced by higher organisms."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "MerLion Pharmaceuticals, Singapore Science Park II, Singapore 117528."}], "Identifier": [], "LastName": "Butler", "ForeName": "Mark S", "Initials": "MS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Newman", "ForeName": "David J", "Initials": "DJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Prog Drug Res", "NlmUniqueID": "1304021", "ISSNLinking": "0071-786X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticholesteremic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Anticholesteremic Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Bacteria"}, {"QualifierName": [], "DescriptorName": "Combinatorial Chemistry Techniques"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fungi"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "NumberOfReferences": "210"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "12", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "1", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "19", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18084912", "10.1007/978-3-7643-8117-2_1"]}}], "PubmedBookArticle": []}